Biotricity is trading 11.11% up at $0.10 as broad U.S. markets rally after August CPI matched expectations, easing inflation concerns.
- The Dow, S&P 500, and Nasdaq each up more than 0.8%, supporting a risk-on move across equities.
- No clear company-specific announcement was identified for September 11, 2026; IR materials show no newer same-day catalyst.
- The move appears primarily global; elevated Treasury yields and oil above $100 remain risks. Confidence is medium amid limited company-specific coverage.